Mechanisms of Sex Differences in TNFR2-Mediated Cardioprotection
- 30 September 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 118 (14_suppl_1) , S38-45
- https://doi.org/10.1161/circulationaha.107.756890
Abstract
Background— TNFR1/TNFR2 signaling may mediate different cellular and molecular responses (injury versus protection) and the balance may be affected by sex hormones. Previous studies have shown that females have improved myocardial functional recovery, TNFR1 signaling resistance, and increased SOCS3 expression after acute ischemia/reperfusion when compared with males. However, it is unknown whether the TNFR2 pathway protects the myocardium from ischemia/reperfusion injury, and if so, whether sex differences exist in TNFR2-mediated cardioprotection. Therefore, we hypothesized that (1) TNFR2 mediates myocardial protection from ischemia/reperfusion through STAT3, SOCS3, and vascular endothelial growth factor in both sexes; and (2) TNFR2 elicits greater protective signaling in females compared with males. Methods and Results— Isolated male and female mouse hearts from TNFR2 knockout, TNFR1/2 knockout, and wild-type (C57BL/6J or B6129SF2/J; n=5 to 6/group) were subjected to 20 minutes ischemia followed by 60 minutes reperfusion. TNFR2 deficiency decreased postischemic myocardial recovery in both sexes but had a greater effect on females. The deleterious effects of TNFR2 ablation were associated with a decrease in mRNA and protein levels of SOCS3, STAT3, and vascular endothelial growth factor as well as an increase in myocardial interleukin-1-beta production in female hearts. However, a significant increase in JNK activation and interleukin-1-beta protein levels was noted in male TNFR2KO hearts after ischemia/reperfusion. Additionally, TNFR1/2 knockout decreased myocardial function in female hearts but not males. This observation was associated with a decrease in mRNA levels of SOCS3, STAT3, and vascular endothelial growth factor and an increase in myocardial p38 mitogen-activated protein kinase activation in females. Conclusions— Sex differences in the mechanisms of TNFR2-mediated cardioprotection occur by increasing STAT3, SOCS3, and vascular endothelial growth factor in females and by decreasing JNK in males.Keywords
This publication has 25 references indexed in Scilit:
- Tumor necrosis factor-α is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Tumor Necrosis Factor-α Receptor p75 Is Required in Ischemia-Induced NeovascularizationCirculation, 2007
- Tumor Necrosis Factor Receptor 1 Signaling Resistance in the Female Myocardium During IschemiaCirculation, 2006
- Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expressionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006
- Late Enhancement of a Left Ventricular Cardiac Fibroma Assessed With Gadolinium-Enhanced Cardiovascular Magnetic ResonanceCirculation, 2005
- Targeted Anticytokine Therapy in Patients With Chronic Heart FailureCirculation, 2004
- TheRole ofSuppressors ofCytokineSignaling(SOCS) Proteins inRegulation of theImmuneResponseAnnual Review of Immunology, 2004
- Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart FailureCirculation, 2003
- Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-αJournal of the American College of Cardiology, 2002
- Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-α, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/ReperfusionCirculation, 1998